CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
114.95
0.17%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024012 %
Charges from full value of position ($-4.56)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024012%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00179 %
Charges from full value of position ($0.34)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00179%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 115.15
Open 114.97
1-Year Change 5.36%
Day's Range 114.49 - 115.74
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 27, 2024 114.95 0.94 0.82% 114.01 115.86 113.39
Dec 26, 2024 115.15 1.24 1.09% 113.91 115.73 113.23
Dec 24, 2024 114.61 0.88 0.77% 113.73 114.77 113.73
Dec 23, 2024 114.00 0.80 0.71% 113.20 114.45 112.86
Dec 20, 2024 114.18 2.09 1.86% 112.09 115.04 112.02
Dec 19, 2024 112.35 1.71 1.55% 110.64 113.22 110.64
Dec 18, 2024 111.79 -1.08 -0.96% 112.87 114.09 111.77
Dec 17, 2024 113.14 1.51 1.35% 111.63 113.77 111.63
Dec 16, 2024 112.58 1.02 0.91% 111.56 113.58 111.56
Dec 13, 2024 113.07 -0.15 -0.13% 113.22 114.19 112.05
Dec 12, 2024 113.79 -0.14 -0.12% 113.93 114.63 113.22
Dec 11, 2024 114.08 -0.37 -0.32% 114.45 115.46 113.92
Dec 10, 2024 115.43 0.79 0.69% 114.64 116.32 114.14
Dec 9, 2024 114.83 -0.23 -0.20% 115.06 115.77 113.76
Dec 6, 2024 115.23 0.18 0.16% 115.05 115.98 115.04
Dec 5, 2024 115.53 0.61 0.53% 114.92 116.15 114.42
Dec 4, 2024 115.90 0.18 0.16% 115.72 116.30 115.18
Dec 3, 2024 116.20 -0.12 -0.10% 116.32 117.36 115.94
Dec 2, 2024 116.75 -1.16 -0.98% 117.91 118.60 116.53
Nov 29, 2024 118.74 0.53 0.45% 118.21 119.12 117.46

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Abbott Company profile

What is Abbott Laboratories?

Abbott Laboratories is a US healthcare company that employs around 99,000 people and delivers its services in over 150 countries worldwide. Abbott produces and distributes a range of products under such popular brands as PediaSure, Glucerna, Similac, Absorb and others. Its mission statement is: “To improve lives by providing cost-effective health care products and services.”

The company focuses on the following healthcare segments: Nutrition, Vascular Care, Diabetes Care, Vision, Pharmaceuticals and Diagnostics. It advocates for innovation in medicine and works to improve vision correction, take heart health treatments to the next level and introduce innovative methods of diabetes management. 

Abbott has also pioneered new ways to screen, diagnose and monitor a wide range of health conditions with greater speed and accuracy. In pharmaceuticals, the company has revolutionised packaging and delivery to meet regional needs and offer access to medicines in areas that once lacked them.

Who are the key people at Abbott Laboratories?

Miles D. White is Chairman and Chief Executive Officer of Abbott. He has held both roles since 1999, and first joined the company back in 1984. Another key figure at Abbott Laboratories is Brian Blaser, Executive Vice President, Diagnostics Products. He leads Abbott's diagnostics, molecular and point-of-care businesses. Robert Ford is Executive Vice President, Medical Devices. 

What is the modern history of Abbott Laboratories?

Abbott was incorporated in 1894, and its initial public offering took place in 1929. Among a number of landmark developments in the second half of the 20th century was the acquisition of M&R Dietetics in 1964, which made the company a leader in nutrition. Abbott’s modern diagnostics business took off in the early 1970s, and in 1985 the FDA approved the firm’s test to identify HIV in blood. In 1998 Abbott introduced Glucerna – a range of snack bars and shakes for diabetics. The first decade of the 21st century saw FDA approval of antibody drug Humira, which became the world’s leading pharmaceutical product.

What are the latest developments at Abbott Laboratories?

In January 2017 Abbott completed the acquisition of St Jude Medical – a development which put the company in a leading position in the medical devices sector. Abbott now holds the No.1 or No.2 positions in nearly every segment of the $30 billion cardiovascular market. In 2017 Abbott also recorded 40 per cent growth in its neuromodulation business, attaining the No.1 spot in spinal cord neurostimulation.

In February 2018, Abbott announced a licensing deal with mid-tech firm Surmodics Inc that could be worth up to $92 million. Under the agreement, Surmodics will exclusively license its SurVeil drug-coated balloon device to Abbott. Surmodics is testing it as a treatment for peripheral artery disease.

Since the start of 2015, the Abbott share price has ranged from a low of around $37 in February 2016 to over $60 in January 2018. The company’s market capitalisation on 2 March 2018 was $103.5 billion. Our ABT chart tracks Abbott’s recent share price movements.

Where does Abbott Laboratories operate?

Abbott is headquartered in Chicago, Illinois. It has a truly global presence, with operations across the Americas, Europe and Asia Pacific – including China, India, Japan, Australia and New Zealand.

Where is Abbott Laboratories traded?

Abbott Laboratories is listed on the New York Stock Exchange. As of 2017, the shares were mainly held by institutional investors such as BlackRock, State Street Corporation and The Vanguard Group. Check out Capital.com for the latest ABT chart.

Industry: Medical Equipment, Supplies & Distribution (NEC)

100 Abbott Park Rd
ABBOTT PARK
ILLINOIS 60064-3500
US

People also watch

US100

21,492.10 Price
-1.130% 1D Chg, %
Long position overnight fee -0.0240%
Short position overnight fee 0.0018%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

2.17 Price
-1.840% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01080

Gold

2,621.49 Price
-0.480% 1D Chg, %
Long position overnight fee -0.0153%
Short position overnight fee 0.0071%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

94,420.30 Price
-0.690% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading